|
If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | |||||||||||||||||||
  Acta Psychiatrica ScandinavicaVolume 115 Issue 1, Pages 4 - 11 Published Online: 14 Dec 2006 © 2010 John Wiley & Sons A/S
Abstract | References | Full Text: HTML, PDF (Size: 529K) | Related Articles | Citation Tracking  Clinical Overview Article Negative symptoms of schizophrenia: a problem that will not go away Copyright 2007 The Authors Journal Compilation 2007 Blackwell Munksgaard KEYWORDS negative symptoms • measurement • antipsychotic medications Stahl SM, Buckley PF. Negative symptoms of schizophrenia: a problem that will not go away. ABSTRACTObjective: Negative symptoms of schizophrenia are a common, enduring, and debilitating component of the psychopathology of schizophrenia. Although efforts thus far to elucidate a distinct schizophrenia subtype based upon negative symptoms have yielded mixed results, there are nevertheless neurobiological correlates of the negative symptom typology. Method: A review of nosology, typology, and assessment tools for determining core negative symptoms in schizophrenia. Results: Negative symptoms can be difficult to evaluate objectively. Current rating scales 'capture' key domains of negative symptoms, in spite of considerable overlap between these domains. However, each objective assessment trades off methodological rigor and detail against brevity of assessment and ease of use. Conclusion: The description of new methods for measuring these devastating symptoms, coupled with the ongoing development of novel antipsychotics and agents that augment antipsychotics have fuelled renewed interest in the evaluation of negative symptoms and optimism that better treatments for negative symptoms can be found. Accepted for publication November 2, 2006 | 
|
|
| ||||||||||||||||
|
|
|||||||||||||||||||
 | Personality and Mental Health |
| |
